Altamira Therapeutics (CYTO)
NASDAQ:CYTO
US Market
Holding CYTO?
Track your performance easily

Altamira Therapeutics (CYTO) Cash flow

597 Followers

Altamira Therapeutics Cash Flow

CYTO's free cash flow for Q was CHF―. For the fiscal year, CYTO's free cash flow was decreased by CHF248.31K and operating cash flow was CHF―. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
-CHF -11.51MCHF -9.62MCHF -13.67MCHF -4.84MCHF -8.39M
Investing Cash Flow
-CHF 1.44MCHF -2.14MCHF -3.51MCHF -2.31MCHF -3.00M
Financing Cash Flow
-CHF 10.62MCHF 9.83MCHF 6.61MCHF 16.96MCHF 7.38M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
-CHF 617.41KCHF -942.22KCHF 694.80KCHF 11.26MCHF 1.38M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
-----CHF 9.79M
Issuance Of Debt
-CHF 1.05M-CHF -18.70KCHF 1.52MCHF 0.00
Repayment Of Debt
-CHF -1.45M-CHF -18.70KCHF 0.00CHF -1.46M
Free Cash Flow
-CHF -11.51MCHF -11.76MCHF -17.00MCHF -7.16MCHF -11.41M
Domestic Sales
------
Foreign Sales
------
Currency in CHF

Altamira Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis